Rare Ovarian Cancer GOG 260

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary
Peritoneal Cancer.